Ronald R Salem MD, MA, MB, ChB, FACS, FRCS(Ed), FRCS (C)

Lapman Professor of Surgery (Oncology) and Professor of Diagnostic Radiology; Section Chief, Surgical Oncology

Departments & Organizations

Yale Medical GroupCancer Center, Yale: Gastrointestinal Cancer Program; Sarcoma Oncology ProgramDiagnostic Radiology | Surgery: Oncology/General Surgery


Ronald R. Salem, MD earned his medical degree from University of Rhodesia and is a Board Certified Surgeon. Passionate about improving the lives of patients with cancer, he is committed to advancing medical and surgical treatment and integrating the latest techniques and minimally invasive surgery in his clinical practice. He is one of the few surgeons in Connecticut with a high volume practice performing the Whipple procedure. Dr. Salem specializes in malignant and pre-malignant diseases of the pancreas, liver and biliary system, the gall bladder, stomach, colon and rectum, lymphoma, neuroendocrine tumors of the pancreas and gastrointestinal tract as well as liver tumors in pregnant women. His research includes a special focus on optimizing clinical outcomes in patients undergoing pancreatic surgery, combined modality therapy for esophageal cancer and the management of benign and malignant liver tumors. He has received many honors and recognitions, including The Best Doctors, N.Y. Metro Area annually for over ten years; Best Doctors in Connecticut and Top Minimally Invasive Surgeons, NY Metro Area. He was recently awarded the prestigious David and Cindy Lefell Award for clinical excellence, the Yale New Haven Hospital Heroes Award, the Smilow Cancer Center Clinical Award the Alvin Feinstein Teaching Award and has received the Chief Resident in Surgery Teaching Award on seven separate occasions.


  • M.D., University of Rhodesia , 1978
  • M.B.Ch.B., University of Rhodesia , 1978

Selected Publication

  • Burtness B, Thomas L, Sipples R, McGurk M, Salikooti S, Cristoforou Mirto G, Salem RR, Sosa J, Kloss R, Rahman Z, Chung G, Lacy J, Murren JR: Phase II trial of weekly docetaxe/irinotecan combinatiuon in advanced pancreatic cancer. Cancer J. 13 (4): 257-262, 2007

Latest Honor and Recognition

  • Master of Arts, Honoris Causa(2006) , Yale University, New Haven, CT